BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
79 hedge funds and large institutions have $42M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
54% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 24
Holders
79
Holding in Top 10
–
Calls
$31K
Puts
$40K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.78M | |
| 3 | +$984K | |
| 4 |
Goldman Sachs
New York
|
+$882K |
| 5 |
Jane Street
New York
|
+$411K |
Top Sellers
| 1 | -$2.73M | |
| 2 | -$2.55M | |
| 3 | -$1.61M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$601K |